Pharma Integrates Returns to London for the Fourth Time

Pharma Integrates, organized by Life Sciences Index, is taking place on November 17–18 at the Grange City Hotel, London. Now in its fourth year, the conference brings together a network of industry leaders who will debate issues and drivers shaping pharma’s future.

The speakers line-up include Bill Burns, former CEO at Roche Pharmaceuticals; Tommy Dolan, vice president, Drug Product Design and Supply Worldwide R&D at Pfizer; Arjan Adegeest, director, CMO Operations at Merck Serono; and Alex Robertson, senior director, Supply Chain Management at AstraZeneca.

Featuring roundtable discussions, the two-day event facilitates the exchange of practical and theoretical knowledge between panelists and delegates. More than 250 senior executives from global pharmaceutical and biotechnology companies, including AstraZeneca, GSK, Pfizer, Sanofi, and Takeda, are expected to be present.

In response to industry demands, this year’s content has been expanded to cover the entire spectrum of pharmaceutical development, from drug discovery to clinical testing and commercial manufacturing. It recognizes the crucial role that contract research plays in getting products to market in a safe, effective, and efficient way.

The theme for Pharma Integrates 2015 is integration. The program is packed with sessions that examine what integration means for the industry, how companies are becoming more specialized, and whether new business models are essential for the future success of drug producers and manufacturers. There will also be discussions on supply-chain issues, outsourcing, funding, and more.

The event, which is sponsored by companies such as Catalent Pharma Solutions, Pfizer, and Patheon, also encompasses an online networking tool to facilitate meetings, a supplier exhibition, panel discussions, and Q&A sessions with some of the biggest names in the industry.

More details on Pharma Integrates 2015 can be found here.